Acute Biphenotypic Leukemia: Clinical Trials

3 trials for Acute Biphenotypic Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Terminated 3

Follow Acute Biphenotypic Leukemia: new trials by email Literature Review of Acute Biphenotypic Leukemia trials Research Report on Acute Biphenotypic Leukemia

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia
Platelet Transfusion - Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia
Phase 2TerminatedFred Hutchinson Cancer Center42017-06-092019-10-21
Lirilumab and Azacitidine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia
Azacitidine, Lirilumab - Acute Biphenotypic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Phase 2TerminatedM.D. Anderson Cancer Center362015-04-202019-09-24
Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Cyclophosphamide, Filgrastim, Fludarabine Phosphate - Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission
Phase 2TerminatedFred Hutchinson Cancer Center462010-05-192023-01-23

Narrower conditions

Leukemia, Biphenotypic, Acute (3)  ·  Leukemia, Myeloid, Acute (2)  ·  Myelodysplastic Syndromes (2)  ·  Burkitt Lymphoma (1)  ·  Hematologic Diseases (1)  ·  Hodgkin Disease (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Lymphoma, B-Cell (1)  ·  Lymphoma, B-Cell, Marginal Zone (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Large-Cell, Anaplastic (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Lymphoma, T-Cell (1)  ·  Multiple Myeloma (1)

Broader conditions

Hemic and Lymphatic Diseases (3)  ·  Immune System Diseases (3)  ·  Immunoproliferative Disorders (3)  ·  Leukemia (3)  ·  Leukemia, Lymphoid (3)  ·  Lymphatic Diseases (3)  ·  Lymphoproliferative Disorders (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Bone Marrow Diseases (2)  ·  Cardiovascular Diseases (2)  ·  Hematologic Diseases (2)  ·  Leukemia, Myeloid (2)  ·  Lymphoma (2)  ·  Lymphoma, Non-Hodgkin (2)

Interventions

Azacitidine (1)  ·  Cyclophosphamide (1)  ·  Filgrastim (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Mycophenolic Acid (1)  ·  Peripheral Blood Stem Cell Transplantation (1)  ·  Platelet Transfusion (1)  ·  Tacrolimus (1)  ·  Whole-Body Irradiation (1)  ·  fludarabine phosphate (1)  ·  lirilumab (1)

Sponsors

Fred Hutchinson Cancer Center (2)  ·  M.D. Anderson Cancer Center (1)

Countries

United States (3)

Top investigators

David Garcia (1)  ·  Naval Daver (1)  ·  Rachel B. Salit (1)

NIH funding

P30CA015704 (1), P30CA016672 (1)